SYNEDGEN
Synedgen is a bio-pharmaceutical company committed to developing novel therapies and products that reduce infection and inflammation at dermal, oral, mucosal, and ophthalmic surfaces. It uses a comprehensive approach using novel polysaccharide derivatives that minimize or treat infections by targeting sites where bacteria enter the human body and encourage healing after infection or acute and chronic damage. Synedgen was formed in 2009 through the merger of BioSTAR West (Claremont, California) ... and Hawaii Chitopure (Honolulu, Hawaii). BioSTAR West was founded in 2005 to generate research and development expertise in biopolymer processing and polymer interactions with mammalian cells and bacteria. This research led to chemical modifications of a natural biopolymer and examination of the molecular interactions of these derivatives with tissue and bacterial pathogens. Synedgen is managed by an experienced team of scientists and business executives with strengths in innovation, synthetic and analytical chemistry, microbiological research, clinical research, regulatory process, product development, corporate partnering, FDA approvals, and successful non-dilutive fundraising.
SYNEDGEN
Industry:
Biotechnology Health Care Health Diagnostics Medical Device Pharmaceutical Therapeutics
Founded:
2009-01-01
Address:
Claremont, California, United States
Country:
United States
Website Url:
http://www.synedgen.com
Total Employee:
11+
Status:
Active
Contact:
(909)447-6858
Email Addresses:
[email protected]
Total Funding:
20.29 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving SPF Apple Mobile Web Clips Icon Google Font API WordPress Google Analytics LetsEncrypt SSL By Default
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Advisors List
Current Employees Featured
Founder
Investors List
Congressionally Directed Medical Research Programs
Congressionally Directed Medical Research Programs investment in Grant - Synedgen
Official Site Inspections
http://www.synedgen.com
- Host name: apache2-zoo.iad1-shared-b8-36.dreamhost.com
- IP address: 173.236.241.210
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821
More informations about "Synedgen"
Synedgen - Crunchbase Company Profile & Funding
Synedgen is a bio-pharmaceutical company committed to developing novel therapies and products that reduce infection and inflammation at dermal, oral, …See details»
Synedgen Announces Appointment of Dr. Laura Saward as Chief …
Feb 10, 2025 government contracts, she brings invaluable expertise to our organization shortly after the signing of our up to $119 million partnership with the Biomedical Advanced Research …See details»
Synedgen, Inc - LinkedIn
Synedgen, Inc | 640 followers on LinkedIn. Improving the treatment of mucosal and dermal diseases with the power of glycopolymers | A forward-thinking, medical technology company dedicated to ...See details»
Contact - Synedgen
Synedgen California. Corporate Headquarters, Research and Development, and Manufacturing 1420 N. Claremont Blvd., Suite 105 D Claremont, CA 91711 (909) 447-6858 …See details»
Synedgen, Inc. Company Profile | Claremont, CA | Competitors ...
Find company research, competitor information, contact details & financial data for Synedgen, Inc. of Claremont, CA. Get the latest business insights from Dun & Bradstreet.See details»
Synedgen - Org Chart, Teams, Culture & Jobs - The Org
View Synedgen's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. This is an unverified company page.See details»
Synedgen 2025 Company Profile: Valuation, Funding
Synedgen General Information Description. Developer of polysaccharide-based drugs designed to enhance and mimic the innate immune system. The company's drugs target the complex interactions at the cell surface and mucosal interface …See details»
Synedgen - Leadership Team - The Org
The Leadership Team at Synedgen is responsible for setting the strategic direction and vision of the company, overseeing operational efficiency, and driving business development initiatives. …See details»
Synedgen Company Profile - Office Locations, Competitors ... - Craft
Synedgen has 5 employees at their 1 location and $15.89 m in total funding,. See insights on Synedgen including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Synedgen - Contacts, Employees, Board Members, Advisors
Synedgen develops novel therapies and products to reduce infection and inflammation of dermal, oral, mucosal, and ophthalmic surfaces. ... Experience the new Crunchbase, powered by AI . …See details»
Synedgen - Funding, Financials, Valuation & Investors - Crunchbase
Organization. Synedgen . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Funding Rounds 9. obfuscated. Total Funding …See details»
Synedgen, Inc - VentureRadar
Synedgen is a biotechnology company using glycochemistry to develop drugs that enhance and mimic the innate immune system. The company’s lead development candidate is SYGN305 …See details»
Synedgen - Overview, News & Similar companies | ZoomInfo.com
Oct 19, 2021 Who is Synedgen. Synedgen is a biotechnology company using glycochemistry to develop drugs that enhance and mimic the innate immune system. The company's lead devel …See details»
Synedgen, Inc Management Team | Org Chart - RocketReach
Looking for a particular Synedgen, Inc employee's phone or email? Find Info Top Synedgen, Inc Management Employees Shenda Baker President and CEO at Synedgen, Inc Claremont, CA, …See details»
Synedgen Announces Appointment of Dr. Laura Saward as Chief …
Feb 10, 2025 Synedgen’s GI-ARS program is funded in whole or in part with Federal funds from the Department of Health and Human Services; Administration for Strategic Preparedness and …See details»
Synedgen Adds Dr. Hal J. Oien to its Board of Directors
Sep 24, 2024 Synedgen, Inc. (Claremont, CA) is a biotechnology company developing Multivalent Innate Immune Signaling Target (MIIST) therapeutics that modulate and enhance …See details»
Synedgen, Inc - VentureRadar
Synedgen is a biotechnology company using glycochemistry to develop drugs that enhance and mimic the innate immune system. The company’s lead development candidate is SYGN305 …See details»
Synedgen Org Chart + Executive Team - The Official Board
Synedgen has 6 executives. Synedgen; Please confirm your deletion . Delete or Cancel . Unfortunately, you don't own enough credit to see this new org chart. To continue, you can …See details»
Our Platform - Synedgen
Synedgen’s platform validation includes MIIST113 (SNSP113), now out-licensed to Synspira Inc. (Framingham, MA), and the lead asset is currently in Phase 2 clinical trials. GI disease …See details»